Post-Marketing Ocular Adverse Events Associated with Tamoxifen and Raloxifene: A Population-Based Pharmacovigilance Study

Abdelrahman Abu Osba, Farah Saleh, Aaryamaan V. Verma, Andrew Mihalache, Abd El Aziz Hendy, Roaa Abu Osba, Amit V. Mishra, Peter J. Kertes, Radha P. Kohly, Rajeev H. Muni, Marko Popovic

Open source

DOI: 10.1097/iae.0000000000004916
Published: 2026-07-10
Container: Retina
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/iae.0000000000004916,
  title = {Post-Marketing Ocular Adverse Events Associated with Tamoxifen and Raloxifene: A Population-Based Pharmacovigilance Study},
  author = {Abdelrahman Abu Osba and Farah Saleh and Aaryamaan V. Verma and Andrew Mihalache and Abd El Aziz Hendy and Roaa Abu Osba and Amit V. Mishra and Peter J. Kertes and Radha P. Kohly and Rajeev H. Muni and Marko Popovic},
  year = {2026},
  journal = {Retina},
  doi = {10.1097/iae.0000000000004916},
  url = {https://doi.org/10.1097/iae.0000000000004916}
}

RIS

TY  - JOUR
TI  - Post-Marketing Ocular Adverse Events Associated with Tamoxifen and Raloxifene: A Population-Based Pharmacovigilance Study
AU  - Abdelrahman Abu Osba
AU  - Farah Saleh
AU  - Aaryamaan V. Verma
AU  - Andrew Mihalache
AU  - Abd El Aziz Hendy
AU  - Roaa Abu Osba
AU  - Amit V. Mishra
AU  - Peter J. Kertes
AU  - Radha P. Kohly
AU  - Rajeev H. Muni
AU  - Marko Popovic
PY  - 2026
JO  - Retina
DO  - 10.1097/iae.0000000000004916
UR  - https://doi.org/10.1097/iae.0000000000004916
ER  -

APA

Osba, A. A., Saleh, F., Verma, A. V., Mihalache, A., Hendy, A. E. A., Osba, R. A., Mishra, A. V., Kertes, P. J., Kohly, R. P., Muni, R. H., & Popovic, M. (2026). Post-Marketing Ocular Adverse Events Associated with Tamoxifen and Raloxifene: A Population-Based Pharmacovigilance Study. Retina. https://doi.org/10.1097/iae.0000000000004916

Source records

crossref · retrieved 2026-09-26T10:41:28.415Z